Work

Minting a new class of Polo-like-kinase inhibitors

Year: 2009

Type: article

Abstract: Commentary to:DH166, a beta-carboline derivative, inhibits the kinase activity of PLK1Jing Zhang, Yan Li, Liang Guo, Rihui Cao, Pei Zhao, Wei Jiang, Qin Ma, Hong Yi, Zhuorong Li, Jiandong Jiang, Jialin Wu, Yanchang Wang and Shuyi Si

Source: Cancer Biology & Therapy

DOI: 10.4161/cbt.8.24.10389

Authors: Paul Dent, David T. Curiel, Steven Grant, Paul B. Fisher

Institution: Virginia Commonwealth University

Language: English

Topic: Microtubule and mitosis dynamics

Subfield: Cell Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: U.S. Department of Defense, Samuel Waxman Cancer Research Foundation, National Institutes of Health, National Cancer Institute, National Institute of Diabetes and Digestive and Kidney Diseases, National Institute of Neurological Disorders and Stroke

Awards: G240198448, G2447325627, G2809070691, G3622168379, Signaling Pathways Regulating Epithelial Cell Survival, Translational Applications of mda-7/IL-24 in Cancer, Pancreatic Cancer Management by Novel Gene Therapy & Dietary Agents, G526054707, Promotion of Nucleoside Analog Induced Apoptosis by HDIs, G6450645852, MDA-7: Novel Cancer Therapeutic Gene

OpenAlex ID: W1965449185

FWCI:

Cites: 12

Cited by:

Related to: 10